优化mRNA脂质纳米颗粒配方的免疫潜力,该配方携带来自病毒和原生动物抗原的序列
Renata S Fernandes1, Gabriela de Assis Burle-Caldas1, Sarah Aparecida Rodrigues Sergio1
1Centro de Tecnologia de Vacinas da, Universidade Federal de Minas Gerais, Belo Horizonte, Belo Horizonte, MG, 31310-260, Brazil.
Journal of nanobiotechnology
|March 19, 2025
概括
新型脂质纳米颗粒 (LNPs) 有效地传递信使RNA (mRNA) 疫苗,显示出对传染病的高免疫性. 这些多功能LNP-mRNA配方为针对各种病原体的新疫苗开发提供了潜力.
科学领域:
- 生物技术是生物技术.
- 疫苗学 疫苗学 疫苗学
- 纳米医学是一种纳米医学.
背景情况:
- 脂质纳米颗粒 (LNP) 已被确立为信使RNA (mRNA) 疫苗的安全有效的输送系统,以COVID-19疫苗为例.
- 在LNP-mRNA疫苗开发中的一个关键挑战是创建多功能配方,以有效地进行体内封装和细胞输送.
- 该研究解决了对新型LNP-mRNA配方的需求,适用于特有和新出现的传染病.
研究的目的:
- 开发和描述一种新的脂质纳米粒子 (LNP) 配方,用于传递信使RNA (mRNA).
- 评估开发的LNP-mRNA配方的物理化学性质,稳定性和生物分布.
- 评估编码病毒和寄生虫抗原的LNP-mRNA配方的免疫性.
主要方法:
- 使用一种新的脂质成分和微流体有机水性沉方法来生产LNP-mRNA配方.
- 用火 luciferase (Luc) 记者mRNA来评估物理化学性质,稳定性和生物分布.
- 在小鼠中使用编码登革热病毒或Leishmania婴儿抗原的mRNA来评估免疫性,将结果与重组蛋白或等离子体DNA免疫进行比较.
主要成果:
- 开发的LNP-mRNA配方表现出高的mRNA封装效率 (>85%),最佳颗粒大小 (~100 nm) 和低的多分散指数 (<0.3).
- 用小鼠进行的生物分布研究显示,在注射后6小时内,注射部位,肝脏和脏中呈现 luciferase 活性.
- 使用病毒和寄生抗原mRNAs的配方显示出高免疫性,诱导与蛋白质或DNA疫苗相比的抗原特异性IgG抗体水平和IFN-γ生产.
结论:
- 新型LNP-mRNA配方具有高度免疫性和稳定性.
- 这些发现表明,LNP-mRNA技术有可能成为针对各种传染病的多功能疫苗候选平台.
- 开发的配方显示出应对现有和新兴传染病威胁的前景.
相关概念视频
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...


